Home » Topics » BioWorld Science

BioWorld Science
RSS

Paracelsian cancels launch of AndroVir

June 12, 1997

Carbovir not associated with mitochondrial toxicity in intact cells

June 12, 1997

Phase III results for AY-4166

June 12, 1997

Clinical safety and efficacy of TS-110 for inflammation and pain

June 12, 1997

Pioglitazone improves insulin resistance in NIDDM

June 12, 1997

New preclinical studies on JTT-501

June 12, 1997

Clinical results in NIDDM reported for troglitazone

June 12, 1997

Nevirapine for prophylaxis of HIV infection

June 11, 1997

Long-term Enbrel safe and effective in RA

June 11, 1997

Update on Alpha-Beta's acquisition and Betafectin trial results timeline

June 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...